These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 22932720)
1. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome. Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720 [TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment: clinical and imaging profile in a memory clinic setting in India. Alladi S; Shailaja M; Mridula KR; Haritha CA; Kavitha N; Khan SA; Divyaraj G; Kaul S Dement Geriatr Cogn Disord; 2014; 37(1-2):113-24. PubMed ID: 24135787 [TBL] [Abstract][Full Text] [Related]
3. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
4. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease. Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311 [TBL] [Abstract][Full Text] [Related]
5. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163 [TBL] [Abstract][Full Text] [Related]
6. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768 [TBL] [Abstract][Full Text] [Related]
7. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment. Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054 [TBL] [Abstract][Full Text] [Related]
9. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers. Rhodius-Meester HF; Koikkalainen J; Mattila J; Teunissen CE; Barkhof F; Lemstra AW; Scheltens P; Lötjönen J; van der Flier WM J Alzheimers Dis; 2016; 50(1):261-70. PubMed ID: 26577521 [TBL] [Abstract][Full Text] [Related]
10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Löwe LC; Gaser C; Franke K; PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431 [TBL] [Abstract][Full Text] [Related]